← The Wire
TYRANasdaq
Tyra Biosciences, Inc.
Pharmaceutical Preparations · DE · CIK 1863127
Develops precision medicines for oncology and genetic conditions using FGFR biology and its SNAP platform
red 8-K · 90d
$1.61B
Market cap
$32.11
Last close
+0.7%
1D
+6.5%
5D
633K
Volume
Price · last 39 sessions-8.6%
May 4L $25.42 · H $37.04Jun 29
85
Total filings
Jun 2, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 2, 202610-Q10-QMay 13, 20268-KResults of OperationsMay 13, 2026DEFA14ADEFA14AApr 17, 2026DEF 14ADEF 14AApr 17, 20268-KExecutive ChangeApr 17, 20268-KExecutive ChangeApr 2, 2026SC 13D/ASC 13D/AMar 6, 20268-KCompany UpdateMar 4, 202610-K10-KMar 2, 20268-KResults of OperationsMar 2, 20268-KExecutive ChangeDec 1, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KCompany UpdateAug 22, 202510-Q10-QAug 14, 20258-KResults of OperationsAug 14, 20258-KCompany UpdateJun 30, 20258-KShareholder VoteMay 29, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEFA14ADEFA14AApr 18, 2025DEF 14ADEF 14AApr 18, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 20258-KExecutive ChangeJan 29, 202510-Q10-QNov 7, 20248-KResults of OperationsNov 7, 20248-KCompany UpdateOct 28, 20248-KExecutive Change · Reg FD DisclosureOct 25, 20248-KEquity IssuanceOct 18, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KSecurity-Holder Rights · Bylaw AmendmentMay 31, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEFA14ADEFA14AMay 7, 20248-KExecutive ChangeMay 7, 2024DEFA14ADEFA14AApr 18, 2024DEF 14ADEF 14AApr 18, 202410-K10-KMar 19, 20248-KResults of OperationsMar 19, 20248-KMaterial Agreement · Equity IssuanceFeb 5, 20248-KCompany UpdateFeb 1, 20248-KCompany UpdateDec 22, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KBylaw AmendmentOct 26, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KShareholder VoteJun 2, 202310-Q10-QMay 4, 20238-KResults of OperationsMay 4, 2023DEFA14ADEFA14AApr 17, 2023DEF 14ADEF 14AApr 17, 202310-K10-KMar 22, 20238-KResults of OperationsMar 22, 20238-KExecutive Change · Company UpdateMar 1, 20238-KCompany UpdateNov 29, 202210-Q10-QNov 3, 20228-KExecutive Change · Results of OperationsNov 3, 20228-KMaterial AgreementOct 3, 202210-Q10-QAug 4, 20228-KResults of OperationsAug 4, 20228-KShareholder VoteJun 14, 202210-Q10-QMay 5, 20228-KResults of OperationsMay 5, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 2022SC 13GTHE SCHEDULE 13GMar 24, 202210-K10-KMar 3, 20228-KResults of OperationsMar 3, 2022SC 13GSC 13GFeb 9, 2022SC 13GSC 13GFeb 8, 202210-Q10-QNov 3, 20218-KResults of Operations · Reg FD DisclosureNov 3, 2021SC 13GSCHEDULE 13GSep 27, 2021SC 13DSC 13DSep 27, 2021SC 13DSCHEDULE 13DSep 27, 2021SC 13DSC 13DSep 24, 2021
Insider Activity
In the 90 days to Mar 25, 2026: 2 sold $1.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Kaplan GillaDirector | Sell | 14,295 | $36.97 | $528K |
| Feb 12, 2026 | Bensen DanielChief Discovery Officer | Sell | 5,872 | $33.37 | $196K |
| Feb 12, 2026 | Bensen DanielChief Discovery Officer | Sell | 2,128 | $31.50 | $67K |
| Jan 12, 2026 | Bensen DanielChief Discovery Officer | Sell | 6,983 | $28.44 | $199K |
| Jan 12, 2026 | Bensen DanielChief Discovery Officer | Sell | 1,017 | $29.08 | $30K |
| Dec 19, 2025 | More Robert JDirector | Sell | 10,000 | $25.00 | $250K |
| Dec 12, 2025 | Bensen DanielChief Discovery Officer | Sell | 8,000 | $22.64 | $181K |
| Nov 21, 2025 | More Robert JDirector | Sell | 246,871 | $20.25 | $5.0M |
| Nov 19, 2025 | Bensen DanielChief Operating Officer | Sell | 49,956 | $16.32 | $815K |
| Nov 18, 2025 | Bensen DanielChief Operating Officer | Sell | 75,633 | $16.07 | $1.2M |
| Nov 17, 2025 | Bensen DanielChief Operating Officer | Sell | 18,572 | $16.11 | $299K |
| Nov 17, 2025 | Bensen DanielChief Operating Officer | Sell | 1,500 | $17.07 | $26K |
| Nov 14, 2025 | Bensen DanielChief Operating Officer | Sell | 110,228 | $16.02 | $1.8M |
| Nov 13, 2025 | Bensen DanielChief Operating Officer | Sell | 1,111 | $16.00 | $18K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance